Notice of Intent for PV Works (VET) PV Express 2
SAM.GOV Due: June 5, 2025 at 04:00 PM UTC
In-Active Sources Sought Source Url

Summary

The FDA has issued a Notice of Intent to award a sole source contract for the PV Works (VET) PV Express 2, which involves the procurement of annual veterinary adverse event pharmacovigilance analytical software licenses and related maintenance support. This contract is specifically aimed at supporting the FDA’s Center for Veterinary Medicine's Adverse Event Program. The FDA intends to award this contract to Assured Information Systems, Ltd., doing business as ENNOV, as they are the only vendor capable of meeting the specific requirements for veterinary pharmacovigilance analytics, including the installation of necessary clinical term dictionaries. While this is not a request for competitive quotations, other firms that believe they can meet these requirements are invited to submit a written response by the specified deadline. This opportunity is particularly suited for software publishers with expertise in veterinary pharmacovigilance and the necessary regulatory compliance capabilities.
Description

The U.S.  Food and Drug Administration (FDA) hereby issues a notice of intent to award a sole source contract in accordance with FAR 5.201. Pursuant to FAR 6.302-1, “Only One Responsible Source and No Other Supplies or Services Will Satisfy the Requirements”, the FDA will sole so

Entities
HAHSDO
Department of Health and Human Services
FADA
Food and Drug Administration
NAICS
513210
Set Aside
None
Place of Performance
Derwood , Maryland
Point of Contact
Full Name Email Phone Type
Alicia Baltimore [email protected] primary